Expanded partnership to help increase patient access to critical genetic screening services including genetic counseling and test result turnaround time This expanded partnership also supports Prelude ...

Two biotech companies are teaming up in the hope of developing a genetic test to determine if someone is genetically predisposed to developing schizophrenia. Rockville-based Vanda Pharmaceuticals is ...

April 24 (Reuters) - Laboratory service provider Labcorp (LH.N), opens new tab said on Wednesday it will acquire Softbank-backed (9434.T), opens new tab Invitae Corp's (NVTAQ.PK), opens new tab assets ...

APOLLO BEACH, Fla., June 27, 2025 (GLOBE NEWSWIRE) -- RetinalGenix Technologies Inc. OTCQB:RTGN (“RetinalGenix” or the “Company”), a pioneering developmental-stage company focused on ophthalmic ...

Nearly a year after Labcorp struck a deal for certain diagnostics assets from BioReference Health, the lab-testing giant is back to buy the firm’s cancer tests. Labcorp is paying $192.5 million for ...

We are at a transformative moment in oncology. Remarkable advancements have led to the identification of biomarkers that can predict treatment response, tests that can detect cancer risk before ...

Genetic testing is rapidly moving genomics from a niche specialty to becoming more integrated into mainstream clinical practice. Once deployed primarily to diagnose rare and inherited conditions after ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Labcorp, the Burlington-based ...

For patients facing a rare disease, a genetic test isn’t the end of their story; it’s often just the beginning. A test result may point to a diagnosis, or it may reveal a genetic variant that we have ...

LabCorp might be able to charge a licensing fee to any scientists who wish to sequence the gene HOMER1 in people who may have autism. In December, LabCorp, a healthcare diagnostics company in ...